PPH ETF Research - HOLDRS Merrill Lynch Pharmaceutical

HOLDRS Merrill Lynch Pharmaceutical (pph)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New ETF | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 107

Threats + Weaknesses = 65

When strengths & opportunities substantially exceed threats & weaknesses an investment in the pph ETF has great long term potential.

ETF Description Update

HOLDRS Merrill Lynch Pharmaceutical (PPH) Description: PPH is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. PPH exchange trading fund (ETF) tracks the General Pharaceutical Index; this etf is not linked to a specific benchmark. HOLDRS Merrill Lynch Pharmaceutical (PPH) falls under the Health & Biotech Equities category. PPH's dividend yield is roughly 2.55%, it has an expense ratio of 0.5%, and is in the equity ETF asset class. HOLDRS Merrill Lynch Pharmaceutical (PPH) focuses its investments in the U.S. region of the world. PPH does not use leverage and PPH's performance is meant to match its benchmark. The PPH ETF belongs to the Health & Biotech sector. An investor can find PPH's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features PPH's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on Merrill Lynch HOLDRs ETF funds or see the ETF research & analysis home page to start.

Portfolio Strategy Update

Be the first to explain HOLDRS Merrill Lynch Pharmaceutical (PPH)'s strategy.

Performance Analysis Update